Silexion Therapeutics Corp - 8-K Filing

Silexion Therapeutics receives Nasdaq Hearings Panel decision granting continued listing subject to specific financing and bid price conditions (Items: 8.01 Other Events)

SEC EDGAR ·

Tickers: $SLXN

Read the full article at SEC EDGAR

More Regulatory news